Virtus Investment Advisers, Inc. Kura Oncology, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $327 Million
- Q3 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 17,085 shares of KURA stock, worth $191,352. This represents 0.05% of its overall portfolio holdings.
Number of Shares
17,085
Previous 14,119
21.01%
Holding current value
$191,352
Previous $81,000
86.42%
% of portfolio
0.05%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding KURA
# of Institutions
213Shares Held
81.2MCall Options Held
900KPut Options Held
228K-
Bvf Inc San Francisco, CA8.62MShares$96.5 Million4.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.12MShares$90.9 Million2.16% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$61.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.67MShares$52.3 Million0.64% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $749M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...